| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00042 | 1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.00041 | 1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.00036 | 1 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.00033 | 1 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.00023 | 1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.00014 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.00013 | 1 |